Liability Risk and Insurance
Shareholders sue Merck
A shareholder suit, run by US law firm Milberg Weiss Bershad Hynes & Lerach llp, alleges that Merck artificially inflated
its reported revenues in 2001 by the inclusion of US$4.6bn revenues that are, in fact, retained by pharmacies. They also claim
that financial statements were not prepared in accordance with generally accepted principles.